USA Rare Earth stock whipsaws as $1.6 billion CHIPS-backed plan meets dilution worry

USA Rare Earth stock whipsaws as $1.6 billion CHIPS-backed plan meets dilution worry

New York, Jan 27, 2026, 11:06 EST — Regular session

  • Shares of USA Rare Earth dropped 4.9% to $25.42 in late morning trade, pulling back from Monday’s surge fueled by a key deal.
  • The company says it holds a non-binding U.S. government letter of intent (LOI) linked to CHIPS Act funding, alongside a $1.5 billion private share sale set to close on Jan. 28.
  • Investors are balancing the scale of the buildout with new equity issuance and the terms tied to the government package.

Shares of USA Rare Earth (USAR) dropped Tuesday, retreating from an earlier surge fueled by U.S. government support for a key financing deal. The stock fell roughly 4.9% to $25.42, after touching a session high of $29.50.

The shift is crucial as Washington doubles down on “critical minerals” supply chains. Rare-earth magnets are key components in defense gear, chip-making equipment, and electric motors. Investors have been eager to back anything linked to government funding — that is, until the numbers start pointing toward dilution.

The deal, as it stands, is just an LOI—not a binding contract. Plus, the conditions attached are anything but light.

On Monday, USA Rare Earth shares jumped 7.9% to close at $26.72, following the company’s announcement of proposed U.S. backing and fresh equity financing. (Yahoo Finance)

A regulatory filing on Monday revealed the Commerce Department LOI covers $1.6 billion, which includes $277 million in proposed awards and a $1.3 billion senior secured loan. The loan, set for a 15-year term, carries an expected rate of Treasury plus 150 basis points. The company also announced a $1.5 billion private investment in public equity (PIPE), a share sale to private investors, priced at $21.50 and slated to close on Jan. 28.

CEO Barbara Humpton described the plan in a press release as “a transformative step” toward building a domestic “mine-to-magnet” supply chain. Commerce Secretary Howard Lutnick called the project “essential” for reestablishing U.S. critical mineral independence. The release also noted that the Energy Department’s National Energy Technology Laboratory signed a letter of intent to work on separation technology connected to USA Rare Earth’s lab and its Round Top deposit. (GlobeNewswire)

Reuters reported the government package targets funding for a Texas mine and a magnet plant, part of a broader effort to reduce dependence on China, which dominates the market. The company clarified it won’t receive a government price floor like the one linked to an earlier MP Materials deal. Humpton told investors bluntly: “The key question everybody has to ask is, ‘What would be the cost of having access to nothing?’” (Reuters)

Analysts wasted no time. Canaccord’s George Gianarikas bumped his price target to $33 from $23. At the same time, Benchmark’s Subash Chandra pushed his target up sharply to $45 from $15. (Barron’s)

Shares of MP Materials climbed roughly 3.0% on Tuesday, highlighting that the sector’s action isn’t centered on a single stock but on how Washington picks its winners—and what it expects back.

The downside is clear-cut. The government LOI doesn’t bind, funding depends on conditions, and the equity raise is hefty. Missed milestones, a rougher capital market, or slower customer growth could trigger more dilution or pushbacks.

The immediate hurdle is the Jan. 28 PIPE closing, along with any follow-up disclosures on customer memoranda and definitive CHIPS paperwork. Traders will see these as the line separating flashy headlines from actual, reliable cash.

Stock Market Today

  • Lunai Bioworks Launches Sentinel AI to Block Creation of Novel Chemical Weapons
    January 27, 2026, 11:20 AM EST. Lunai Bioworks (NASDAQ: LNAI) introduced Sentinel, a transformer-based AI safeguard embedded in large language models to prevent the design of new chemical weapons. Utilizing proprietary toxicology and in-vivo datasets, Sentinel screens molecular outputs in real time to stop hazardous compounds at their source. The launch responds to rising concerns about dual-use risks of AI in chemistry and biology as advanced generative models accelerate novel chemical agent development. Lunai's suite includes Pathfinder, for rapid chemical threat identification, and Counteract, for developing medical countermeasures. With chemical weapons re-emerging in modern conflicts, Lunai positions itself at the forefront of AI-driven biosecurity, aligning with calls from leaders at Anthropic and OpenAI to embed safety measures directly within AI systems.
Hecla Mining stock slides as Casa Berardi sale and 2026 outlook sink in
Previous Story

Hecla Mining stock slides as Casa Berardi sale and 2026 outlook sink in

GOOG stock price rises as EU opens Google data-sharing proceedings ahead of Alphabet earnings
Next Story

GOOG stock price rises as EU opens Google data-sharing proceedings ahead of Alphabet earnings

Go toTop